Delta sleep-inducing peptide (DSIP) is a nonapeptide discussed in neuropeptide, chronobiology, and stress-response research. The original overview of this page asks three questions: DSIP sequence and historical terminology, chronobiology research-model limitations, and short-peptide identity and stability checks. A companion page on study design is at What Is DSIP? Study Design and Verification Notes.
Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only. Published findings below are attributed to the cited papers. They are not claims about a Velnacor lot and are not instructions for use in people or animals.
DSIP sequence and historical terminology
Schoenenberger and Monnier isolated a peptide from rabbits that they named delta-sleep-inducing peptide (DSIP) and reported the amino-acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. They also reported that the isolated peptide, and synthesized material of that sequence, enhanced slow-wave (delta) and spindle EEG activity after the intracerebral administration design they described in rabbits (Schoenenberger and Monnier, 1977). That sequence language, if used on a quotation, should match the report. DSIP is a short peptide with a historical name; the name is not, by itself, evidence of a reproducible sleep-factor mechanism.
Limits of the historical sleep-factor claim
Kovalzon and Strekalova reviewed the subsequent literature and argued that the link between DSIP and sleep was never further characterized in a satisfactory way, in part because the DSIP gene, protein, and a possible related receptor were not isolated. They concluded that the hypothesis of DSIP as a sleep factor was extremely poorly documented and still weak (Kovalzon and Strekalova, 2006). That review is cited here so that historical EEG observations are not read as a settled chronobiology mechanism or as a use instruction. Laboratory work that uses a synthetic nonapeptide still has to specify the sequence, the endpoints, and the controls, as discussed on the study-design page.
Short-peptide identity and stability checks
What Is a Peptide COA?, How to Read a Peptide COA, HPLC vs Mass Spectrometry for Peptide Lot Review, Third-Party Peptide Testing, Explained, and lot traceability apply independently to this row. Stability and sample age belong in the receiving file.
DSIP appears in Velnacor’s research-material catalog (internal product record, slug dsip). There is not a standalone public landing page for every catalog name; use the product directory and the COA Library, then confirm the exact sequence and current-lot documents in the inquiry. For packing at supply scale, see wholesale peptides.
The 1977 paper’s EEG observations followed an intracerebral administration design in rabbits. That historical design is not a laboratory instruction, and it is not evidence that a contemporary vial will reproduce a sleep-factor effect. A current experiment should name the sequence, the matrix, the endpoints, and the controls actually used, and it should record sample age. The companion study-design page discusses vehicle, timing, and how to read a DSIP certificate without repeating the origin story at the same length.
Selected published literature
- Schoenenberger GA, Monnier M. Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proceedings of the National Academy of Sciences. 1977;74(3):1282-1286. doi:10.1073/pnas.74.3.1282. PubMed 265572. Cited for sequence and historical EEG observations, not as a use instruction.
- Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. Journal of Neurochemistry. 2006;97(2):303-309. doi:10.1111/j.1471-4159.2006.03693.x. PubMed 16539679. Review article; cited for limits of the historical sleep-factor claim.
Sourcing notes for qualified buyers
Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.
Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.
Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.